Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer

NCT07094685 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Michigan Rogel Cancer Center

Collaborators